Max Robotics — Global Service Robot Directory + US Certification

About

Chenghao Lu is a cardiac surgeon whose research focuses on advancing minimally invasive techniques for the treatment of cardiac tumors, particularly cardiac myxoma. His major contributions lie in comparing the safety, efficacy, and perioperative outcomes of emerging surgical approaches—including total thoracoscopic and robotically-assisted methods—against conventional sternotomy. In his most-cited work, a 2023 single-center retrospective study, Lu demonstrated that the thoracoscopic and robotic approaches yield comparable clinical outcomes for myxoma resection, with the robotic method offering enhanced dexterity and visualization. This study has garnered 6 citations, reflecting growing interest in robotic cardiac surgery. His 2024 follow-up, with 4 citations, further validates the robotic approach by showing superior perioperative outcomes, such as reduced blood loss and shorter hospital stays, compared to traditional sternotomy. Lu’s research is pivotal in establishing evidence-based guidelines for minimally invasive cardiac surgery, potentially reducing patient trauma and recovery time. His work underscores a shift toward precision, less invasive interventions in cardiothoracic surgery, positioning him as a key contributor to this evolving field.